Literature DB >> 17704887

The usefulness of chromoendoscopy with methylene blue in Barrett's metaplasia and early esophageal carcinoma.

N Ormeci1, B Savas, S Coban, M Palabiyikoğlu, A Ensari, I Kuzu, N Kursun.   

Abstract

BACKGROUND: Barrett's esophagus is a condition that is premalignant for adenocarcinoma of the esophagus and the esophagogastric junction. Early detection of Barrett's metaplasia and dysplasia is very important to decrease the mortality and morbidity from esophageal adenocarcinoma cancer. This study aimed to evaluate the effectiveness of methylene blue-targeted biopsies in the differential diagnosis of intestinal metaplasia, dysplasia, and superficial esophageal carcinoma.
METHODS: A total of 109 patients (43 women and 66 men; average age, 62.32 +/- 10.61 years; range, 33-82 years) were enrolled for the study. Four groups were designed before endoscopic examinations. The patients for these groups were selected at the conventional endoscopy, and then chromoendoscopy was performed. The esophagus was stained with methylene blue, after which six biopsies were taken from stained and unstained areas.
RESULTS: Conventional and chromoendoscopic assessments were compared with histopathologic examination. The sensitivity of chromoendoscopy for Barrett's epithelium was superior to that of conventional endoscopy (p < 0.05). However, there was no statistical difference between the two methods in the diagnosis of esophagitis or esophageal carcinoma (p > 0.05). Stained biopsies were superior to unstained biopsies in terms of sensitivity for Barrett's epithelium and esophageal carcinoma (p < 0.001).
CONCLUSION: Chromoendoscopy is useful for delineating Barrett's epithelium and for indicating the correct location for securing biopsies where dysplasia or early esophageal cancer is suspected.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17704887     DOI: 10.1007/s00464-007-9463-x

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  44 in total

1.  Methylene blue chromoendoscopy for Barrett's esophagus: coming soon to your GI unit?

Authors:  M I Canto
Journal:  Gastrointest Endosc       Date:  2001-09       Impact factor: 9.427

2.  Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus.

Authors:  P Sharma; A P Weston; M Topalovski; R Cherian; A Bhattacharyya; R E Sampliner
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

3.  Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus.

Authors:  M Guelrud; I Herrera; H Essenfeld; J Castro
Journal:  Gastrointest Endosc       Date:  2001-05       Impact factor: 9.427

Review 4.  Gastroesophageal reflux disease and Barrett's esophagus.

Authors:  J J G H M Bergman
Journal:  Endoscopy       Date:  2005-01       Impact factor: 10.093

5.  Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries.

Authors:  A A Botterweck; L J Schouten; A Volovics; E Dorant; P A van Den Brandt
Journal:  Int J Epidemiol       Date:  2000-08       Impact factor: 7.196

6.  Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.

Authors:  M Solaymani-Dodaran; R F A Logan; J West; T Card; C Coupland
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

7.  Magnifying chromoendoscopy of the esophagus: in-vivo pathological diagnosis using an endocytoscopy system.

Authors:  Y Kumagai; K Monma; K Kawada
Journal:  Endoscopy       Date:  2004-07       Impact factor: 10.093

Review 8.  Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma.

Authors:  Michelle Beilstein; Debra Silberg
Journal:  Gastroenterol Clin North Am       Date:  2002-06       Impact factor: 3.806

9.  Methylene blue staining for intestinal metaplasia of the gastric cardia with follow-up for dysplasia.

Authors:  T G Morales; A Bhattacharyya; E Camargo; C Johnson; R E Sampliner
Journal:  Gastrointest Endosc       Date:  1998-07       Impact factor: 9.427

10.  Yield of intestinal metaplasia in patients with suspected short-segment Barrett's esophagus (SSBE) on repeat endoscopy.

Authors:  Thomas F Jones; Prateek Sharma; Bisher Daaboul; Rachel Cherian; M Mayo; Margarita Topalovski; Allan P Weston
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

View more
  7 in total

Review 1.  Oesophageal cancer--an overview.

Authors:  Michael Schweigert; Attila Dubecz; Hubert J Stein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-08       Impact factor: 46.802

Review 2.  Endoscopic evaluation and advanced imaging of Barrett's esophagus.

Authors:  Kenneth K Wang; Ngozi Okoro; Ganapathy Prasad; Michel WongKeeSong; Navtej S Buttar; Jianmin Tian
Journal:  Gastrointest Endosc Clin N Am       Date:  2011-01

3.  Nitroreductase-triggered activation of a novel caged fluorescent probe obtained from methylene blue.

Authors:  Jungeun Bae; Louis E McNamara; Manal A Nael; Fakhri Mahdi; Robert J Doerksen; Gene L Bidwell; Nathan I Hammer; Seongbong Jo
Journal:  Chem Commun (Camb)       Date:  2015-08-18       Impact factor: 6.222

4.  Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction.

Authors:  Jerard Seghatchian; Wilhelm G Struff; Stefan Reichenberg
Journal:  Transfus Med Hemother       Date:  2011-01-27       Impact factor: 3.747

5.  Imaging Dynamic Peroxynitrite Fluxes in Epileptic Brains with a Near-Infrared Fluorescent Probe.

Authors:  Jiong-Sheng Hu; Chenwen Shao; Xueao Wang; Xiaojiao Di; Xuling Xue; Zhi Su; Jing Zhao; Hai-Liang Zhu; Hong-Ke Liu; Yong Qian
Journal:  Adv Sci (Weinh)       Date:  2019-06-11       Impact factor: 16.806

Review 6.  Early diagnosis of oesophageal cancer.

Authors:  E L Bird-Lieberman; R C Fitzgerald
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

7.  Deformylation reaction-based probe for in vivo imaging of HOCl.

Authors:  Peng Wei; Wei Yuan; Fengfeng Xue; Wei Zhou; Ruohan Li; Datong Zhang; Tao Yi
Journal:  Chem Sci       Date:  2017-11-03       Impact factor: 9.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.